Recombinant Human ITGAV & ITGB8 Protein, His-tagged

• Cat.No.: ITGAV & ITGB8-756H
• Product Overview: Recombinant Human ITGAV (Phe 31 - Val 992) (NP_002201) & ITGB8 (Glu 43 - Arg 684) (NP_002205) Protein, fused with polyhistidine tag at the C-terminus and followed by a acidic tail (ITGAV) & a basic tail at the C-terminus (ITGB8), was expressed in HEK293.

Specification

• Species: Human
• Source: HEK293
• Tag: His
• ProteinLength: Phe 31 - Val 992 (ITGAV) & Glu 43 - Arg 684 (ITGB8)
• Predicted N Terminal: Phe 31 (ITGAV) & Glu 43 (ITGB8)
• Form: Lyophilized from sterile Tris, NaCl and MgCl2, 10% trehalose.
• Molecular Mass: Human ITGAV & ITGB8 Heterodimer Protein, produced by co-expression of ITGAV and ITGB8, has a calculated MW of 113 kDa (ITGAV) and 75.5 kDa (ITGB8). The reducing (R) protein migrates as 145 kDa (ITGAV) and 100-116 kDa (ITGB8) respectively due to glycosylation.
• Endotoxin: Less than 1.0 EU per μg by the LAL method.
• Purity: >95% as determined by SDS-PAGE.
• Stability: Samples are stable for up to twelve months from date of receipt at -70ºC.
• Storage: Store it under sterile conditions at -20ºC~-70ºC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4℃ before opening to recover the entire contents.

Gene Information

• Official Symbol: ITGAV & ITGB8